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Background: Diastolic wall strain (DWS), defined using posterior wall thickness (PWT) measurements from standard
echocardiographic images (DWS = [PWT(systole)-PWT(diastole)]/PWT(systole)), has been proposed as a marker of left
ventricular (LV) diastolic stiffness. However, the equation for DWS is closely related to systolic radial strain, and
whether DWS is associated with abnormal cardiac mechanics (reduced systolic strains and diastolic tissue
velocities) is unknown. We sought to determine the relationship between DWS and systolic and diastolic
cardiac mechanics.
Methods: We calculated DWS and performed speckle-tracking analysis in a large population- and family-based study
(Hypertension Genetic Epidemiology Network [HyperGEN]; N = 1907 after excluding patients with ejection fraction
[EF] < 50% or posterior wall motion abnormalities). We measured global longitudinal, circumferential, and radial strain
(GLS, GCS, and GRS, respectively) and early diastolic (e’) tissue velocities, and we determined the independent
association of DWS with cardiac mechanics using linear mixed effects models to account for relatedness among
study participants. We also prospectively performed receiver-operating characteristic (ROC) analysis of DWS for
the detection of abnormal cardiac mechanics in a separate, prospective validation study (N = 35).
Results: In HyperGEN (age 51 ± 14 years, 59% female, 45% African-American, 57% hypertensive), mean DWS was
0.38 ± 0.05. DWS decreased with increasing comorbidity burden (β-coefficient −0.013 [95% CI −0.015, −0.011];
P < 0.0001). DWS was independently associated with GLS, GCS, GRS, and e’ velocity (adjusted P < 0.05) but not LV
chamber compliance (EDV20, P = 0.97). On prospective speckle-tracking analysis, DWS correlated well with GLS,
GCS, and GRS (R = 0.61, 0.57, and 0.73, respectively; P < 0.001 for all comparisons). C-statistics for DWS as a diagnostic
test for abnormal GLS, GCS, and GRS were: 0.78, 0.79, and 0.84, respectively.
Conclusions: DWS, a simple parameter than can be calculated from routine 2D echocardiography, is closely associated
with systolic strain parameters and early diastolic (e’) tissue velocities but not LV chamber compliance.
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Left ventricular (LV) diastolic dysfunction is common in
the general population, and is associated with incident
heart failure and increased mortality [1,2]. The patho-
physiology of diastolic dysfunction is complex, but can be
simply described as impaired LV myocardial relaxation
and/or increased LV stiffness, both of which can lead to
increased LV filling pressures at rest or with exercise.* Correspondence: sanjiv.shah@northwestern.edu
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unless otherwise stated.Although Doppler echocardiography is able to detect
impaired LV relaxation and elevated LV filling pressures
quite well, the detection of reduced LV compliance (i.e.,
increased LV stiffness) has proven to be more difficult,
requiring invasive pressure-volume analysis for calcula-
tion of the end-diastolic pressure-volume relationship
(EDPVR).
Recently, a non-invasive, load-independent, and repro-
ducible estimator of LV stiffness using 2-dimensional (2D)
echocardiography, namely diastolic wall strain (DWS),
has been proposed [3,4]. DWS, an extension of linearl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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wall thickness in systole (PWTs) and diastole (PWTd) to
approximate LV stiffness [4]. According to the theory,
decreased wall thinning during diastole reflects reduced
LV compliance and distensibility, and thus, increased
LV stiffness.
However, DWS, as it name implies, is closely related to
systolic strain. DWS, calculated as [(PWTs) – (PWTd)]/
(PWTs), can be simplified purely in terms of myocardial
(wall) strain, defined as [(PWTs) – (PWTd)]/(PWTd). By
rearranging the two equations, DWS can be expressed as
[(wall strain)/(1 + wall strain)] [4]. Takeda et al., whose
work validated the use of DWS, failed to demonstrate a
correlation between tissue-Doppler derived strain and
DWS [4]. However, speckle-tracking echocardiography
holds several advantages over tissue-Doppler in measuring
strain, including superior reliability, less angle dependence,
and greater ability to differentiate normal from dysfunc-
tional myocardial segments [5].
Though Takeda et al. demonstrated that DWS corre-
lates moderately well (R = −0.47, P < 0.05) with invasive
measurements of myocardial stiffness [4], uncertainty
still remains in how best to interpret this new marker. A
recent editorial has framed the debate [6]. DWS can
conversely be thought of as an index of wall thickening,
not just wall thinning, and may therefore measure LV
systolic function. Further, DWS should theoretically
correlate well with radial strain, which is itself a systolic
index. That DWS may actually correlate well with both
systolic and diastolic indices suggests, in fact, that DWS
is rather an overall marker of myocardial health and
performance.
The evaluation of echocardiograms from the Hyperten-
sion Genetic Epidemiology Network (HyperGEN) study
permits a robust assessment of the relationship between
DWS and cardiac mechanics. HyperGEN, conducted from
1996–2002, originally sought to determine the genetic
basis for familial hypertension. Advantages of the Hyper-
GEN study include a bi-racial sample of approximately
3600 participants, comprehensive clinical and laboratory
data collection, and 2D/Doppler echocardiographic data
[7]. Though echocardiograms were performed at a time
prior to digital storage, we have successfully implemented
a technique to convert analog echocardiograms to digital
format, permitting post-hoc speckle-tracking with the
subsequent determination of cardiac mechanics [8].
Therefore, we sought to determine the association of
DWS with LV systolic and diastolic mechanics. We hypoth-
esized that DWS correlates with both systolic and diastolic
measures of LV performance. We further hypothesized that
reduced DWS is associated with systolic LV mechanics
(i.e., decreased LV strain), even when adjusting for LV
geometry and echocardiographic indices of filling pressures
and myocardial relaxation.Methods
Study population
HyperGEN, part of the National Institutes of Health
Family Blood Pressure Program (FBPP), is a cross sectional-
study consisting of five U.S. sites, while four participated
in an ancillary echocardiographic study (Salt Lake City,
Utah; Forsyth County, NC; Minneapolis, Minnesota; and
Birmingham, Alabama). The goal of HyperGEN was to
identify and characterize the genetic basis of familial
hypertension; complete details of the HyperGEN study
design have been reported previously [7]. Study eligibility
required a diagnosis of hypertension prior to the age of
60 years and at least one sibling willing to participate in
the study. Hypertension was defined by an average systolic
blood pressure ≥ 140 mmHg or an average diastolic
blood pressure ≥ 90 mmHg (on at least 2 separate clinic
visits) or by self-reporting treatment for hypertension.
Age-matched normotensive patients were also enrolled
as control subjects. Individuals with a history of type 1
diabetes mellitus or severe chronic kidney disease were
excluded due to the high risk of secondary forms of
hypertension. None of the study participants had symp-
tomatic heart failure. All HyperGEN study participants
gave written informed consent, and the HyperGEN study
was approved by each study site’s local institutional review
board. For the present study, we restricted our initial
population to 2150 participants based upon videotapes
available at the time of analysis, sampled at random from
all four participating centers.
Clinical characteristics
Demographic, clinical, and laboratory data were collected
during the initial HyperGEN visit. Height, weight, blood
pressure, and waist circumference were measured by a
technician. Histories of myocardial infarction, transient
ischemic attack, or stroke were obtained by self-report. Dia-
betes mellitus was defined by fasting glucose ≥ 126 mg/dl,
use of hypoglycemic medication, or a self-reported history.
Obesity was defined by a body mass index ≥ 30 kg/m2.
Chronic kidney disease was defined by an estimated
glomerular filtration rate ≤ 60 ml/min/1.73 m2.
Echocardiography
Doppler, 2D, and M-mode echocardiograms were acquired
using standardized acquisition protocols and stored in ana-
log format (high grade, medical quality videocassette tapes)
at the time of visit [9,10]. Cardiac structure and function
were quantified as recommended by the American Society
of Echocardiography [11,12]. LV mass was calculated
and indexed to body surface area, and LV hypertrophy
was defined by an LV mass index > 95 g/m2 in women
or > 115 g/m2 in men. DWS was calculated as [(PWTs) –
(PWTd)/(PWTs)] [3,4]. Participants with missing posterior
wall thickness values (N = 81), EF < 50% (N= 118), and
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cluded from analyses, consistent with criteria from
previous studies [3,4].
Digitization and interpretation of image quality
Archived echocardiograms in analog format were con-
verted to digital format using the TIMS 2000 DICOM
System (Foresight Imaging, Chelmsford, MA). Cine loops
of 2–4 cardiac cycles from the parasternal short axis
(papillary muscle level) and apical four chamber views
were digitized at a frame rate of 30 to 40 frames per
second and stored offline in DICOM format. Each study
was assessed for image quality by an experienced operator,
blinded to all other clinical and echocardiographic data,
using a 4-point scale based on the degree of endocardial
border visualized (1 = 0-25%; 2 = 25%-50%; 3 = 50%-75%;
4 = 75%-100%), similar to scales used previously [13,14].
Two-dimensional speckle-tracking analysis
Digitized cine loops were analyzed using 2D wall motion
tracking software [2D Cardiac Performance Analysis
(CPA), TomTec v4.5, Unterschleisshein, Germany]. After
isolating the highest quality cardiac cycle, the endocardial
and epicardial borders were traced at end-systole in
each view. Computerized speckle-tracking analysis was
performed, and endocardial and epicardial border tracings
were manually adjusted to optimize tracking.
Components of LV strain (global longitudinal, radial,
and circumferential) and tissue velocities (septal and
lateral e’) values were recorded. For ease of display, all
strain values were converted to absolute values (i.e.,
longitudinal and circumferential strain values were con-
verted from negative to positive values). Lower absolute
strain values, lower e’ tissue velocities, and higher E/e’
ratio were used to indicate worse cardiac function.
Speckle-tracking tissue velocities were used instead of
tissue Doppler velocities since HyperGEN echocardio-
grams were acquired at a time prior widespread use of
tissue Doppler technology. However, we converted speckle-
tracking echocardiography-derived tissue velocities into
tissue Doppler velocities using a regression equation
constructed from a separate cohort of 100 prospectively
studied patients referred to the Bluhm Cardiovascular
Institute (Northwestern Memorial Hospital, Chicago,
IL) for clinically indicated echocardiography with tissue
Doppler imaging (Philips ie33 [Philips Medical Systems,
Andover, MA] or GE Vivid 7 [GE Medical Systems,
Milwaukee, WI]). All patients gave written, informed
consent, and the Northwestern University Institutional
Review Board approved the study of these patients. These
echocardiograms were analyzed using the same software
used in the analysis of HyperGEN participants (2D
Cardiac Performance Analysis [TomTec, Unterschleisshein,
Germany]), and velocities from the 2 methods (speckle-tracking vs. tissue Doppler) were compared. A regres-
sion equation was constructed for each tissue velocity
[(septal tissue Doppler e’ velocity = 1.39*(speckle-track-
ing tissue e’ velocity) + 1.89 cm/s; lateral tissue Doppler
e’ velocity = 1.47*(speckle-tracking tissue e’ velocity) +
5.67 cm/s)]. A validation of the digitization and speckle-
tracking techniques employed here has been published
elsewhere [8].
Calculation of the single-beat end-diastolic pressure
volume relationship
In order to compare DWS to a measure of LV chamber
compliance (LV EDPVR), we calculated LV end-diastolic
stiffness as the slope of the EDPVR on pressure-volume
analysis. The single-beat method was employed, and we
calculated EDV20 (the predicted LV end-diastolic volume
at an idealized LV end-diastolic pressure of 20 mmHg)
based on mean α and β coefficients as previously described
[15]. In order to use this method, an estimate of diastolic
filling pressure (i.e. E/e’ ratio) is required. The lateral
E/e’ ratio (which is preferred over the septal E/e’ ratio
in participants with preserved ejection fraction) [16] was
converted into LV filling pressure using a previously
published formula [17].
Validation study – prospective digital speckle-tracking
echocardiography
To determine the clinical utility of DWS for the detection
of abnormal strain parameters, we conducted an additional
prospective validation study using digital speckle-tracking
echocardiography-derived strain measurements. The valid-
ation cohort consisted of patients (N = 35) recruited from
the Bluhm Cardiovascular Institute echocardiography
laboratory. Each patient underwent echocardiography
(GE Vivid 7) for research purposes using a pre-defined
protocol, which included dedicated, zoomed-in views of
the LV in the parasternal short axis and apical 4-, 3-,
and 2-chamber views. The sector width and depth were
minimized to ensure an adequate frame rate (50–70
fps). PWT measurements and speckle-tracking analysis
were performed offline using EchoPAC software (GE
Medical Systems, Milwaukee, WI). The speckle-tracking
and DWS measurements were made > 3 months apart and
both sets of measurements were made in a blinded fash-
ion. All patients enrolled in the validation study provided
written, informed consent, and the study was approved
the Northwestern University Institutional Review Board.
Statistical analysis
Clinical characteristics, laboratory data, and both conven-
tional echocardiographic parameters and speckle-tracking
parameters are displayed for the total HyperGEN co-
hort. Continuous data are presented as mean ± standard
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We evaluated intra- and inter-observer reliability in
a randomly selected sample of 95 HyperGEN study
participants. These echocardiograms were analyzed
by 2 independent readers, blinded to their previous
measurements, the other reader’s measurements, and
all other data. Intra-observer measurements were per-
formed one month after initial measurement. We
evaluated the reproducibility of speckle-tracking mea-
surements by calculating intra-class correlation coeffi-
cient, mean bias (using Bland-Altman analysis), and
coefficient of variation. These data have been previously
published [18].
In HyperGEN, we performed Pearson correlation ana-
lyses to determine the relationship between DWS and
several systolic and diastolic echocardiographic indices.
Next, we created multivariable models to determine
the independent association between DWS and cardiac
mechanics using mixed-effects linear regression, thereby
accounting for relatedness among HyperGEN partici-
pants. Further models were constructed that additionally
adjusted for indices of impaired relaxation (tissue e’
velocity, averaged from the septal and lateral values) and
elevated filling pressures (E/e’ ratio, similarly averaged
from the septal and lateral values) to determine whether
DWS is independently associated with systolic cardiac
mechanics beyond its association with these diastolic
parameters. β-coefficients were reported per 0.01-unit
change in DWS.
Covariates entered into the baseline multivariable model
(besides family membership) included speckle-tracking
analyst, image quality, and field center. Covariates selected
for inclusion into additional regression models were based
on a combination of clinical relevance (pre-specified based
on face validity) and association with DWS in previous
studies. These additional covariates (beyond the baseline
model) included age, sex, LV mass index, ejection fraction,
and wall motion score index. A two-sided p-value < 0.05
was considered statistically significant.
For the prospective validation study, we first created
scatterplots and calculated Pearson correlation coefficients
to determine the correlation between DWS and strain
measurements. We then used published data on GLS,
GCS, and GRS [19] to determine abnormal values for these
parameters (GLS < 12.5%, GCS < 15%, or GRS < 35%.), and
stratified the validation study patients into normal and
abnormal groups by each strain parameter. Finally, we
conducted receiver-operating characteristic (ROC) ana-
lyses to determine the area under the ROC curve (i.e.,
c-statistics) for DWS as a diagnostic test for the detection
of abnormal systolic strain.
All statistical analyses were performed using Stata 12
software (StataCorp, College Station, TX).Results
Characteristics of the HyperGEN study participants
Descriptive characteristics of the study sample from
HyperGEN are displayed in Table 1. As stated above, from
the original cohort of 2150 participants, individuals with
missing DWS values (N = 81), EF < 50% (N = 118), and
posterior wall motion abnormalities (N = 44) were
excluded, leaving 1907 participants for analysis. Participants
were sampled from all 4 participating sites, representing
1007 unique families. The mean age was 51 ± 14 years
and 59% were female. The distribution of ethnicities
was largely biracial and nearly even (54% white, 45%
African American, and 1% other). Comorbidities were
common, and medication use reflected standard therapies
used in the comorbidities detailed in Table 1. Blood
pressure was relatively well controlled (126 ± 20/72 ±
11 mmHg), and most study participants were obese
(mean body mass index 31 ± 7 kg/m2).
2D, Doppler, and speckle-tracking echocardiographic
parameters are displayed in Table 2. Average values for
LV structural parameters fell within normal limits,
though roughly one-sixth (17%) had evidence of LV
hypertrophy based on sex-specific cut-offs for elevated
levels of LV mass index. Images upon which speckle-
tracking was performed were generally of high quality.
In the parasternal short-axis and apical four chamber
views, 86% and 97% of images had an image quality
score ≥ 2, respectively. Interobserver and intraobserver
reliability data was excellent for all parameters (as shown
previously [18]).
Correlation between DWS and echocardiographic systolic
and diastolic indices in HyperGEN
Figures 1 and 2 show the relationship between DWS
quintiles and LV strain parameters and diastolic indices,
respectively. Table 3 demonstrates the correlation between
DWS and both 2D and speckle-tracking echocardio-
graphic systolic and diastolic indices. There was a modest
but significant correlation between DWS and many
systolic and diastolic indices. The strongest correlation
was with midwall fractional shortening, a systolic index
(R = 0.56, P < 0.001). DWS did not correlate with EF.
Importantly, DWS did not correlate with measures of
LV chamber compliance (EDV20 and early mitral inflow
[E] deceleration time).
Independent association of DWS with cardiac mechanics
in HyperGEN
Table 4 shows the association between DWS and cardiac
mechanics using various linear mixed-effects models.
DWS was associated with global longitudinal strain and
e’ velocity on minimally-adjusted analysis (Model 1).
After further adjustment for age, sex, LV mass-index,
wall motion score index, and EF, DWS was associated
Table 1 Clinical characteristics of the HyperGEN study
sample
Characteristic All HyperGEN
participants (N = 1907)
Age, y 51 ± 14
Female, n (%) 1129 (59)
Ethnicity, n (%)
● White 1032 (54)
● African-American 867 (45)
● Other 7 (1)
Recruiting center, n (%)
● Birmingham, Alabama 531 (28)
● Minneapolis, Minnesota 376 (20)
● Forsyth County, North Carolina 537 (28)
● Salt Lake City, Utah 463 (24)
Comorbidities, n (%)
● Hypertension 1085 (57)
● Obesity 897 (47)
● Diabetes mellitus 314 (16)
● Chronic kidney disease 158 (8)
● Myocardial infarction 83 (4)
● Transient ischemic attack or stroke 77 (4)
Medications, n (%)
● Anti-hypertensive medication 950 (50)
● Angiotensin-converting enzyme inhibitor 381 (20)
● Angiotensin receptor blocker 51 (3)
● Alpha blocker 145 (8)
● Beta-blocker 245 (13)
● Calcium channel blocker 417 (22)
● Loop diuretic 108 (6)
● Thiazide diuretic 244 (13)
● Oral hypoglycemic 195 (10)
● Insulin 69 (4)
● Lipid lowering medication 163 (9)
● Statin 144 (8)
Physical examination:
● Systolic blood pressure, mm Hg 126 ± 20
● Diastolic blood pressure, mm Hg 72 ± 11
● Body mass index, kg/m2 31 ± 7
● Waist circumference, cm 102 ± 16
Laboratory data:
● Sodium, mEq/L 142 ± 2
● Creatinine, mg/dl 0.97 ± 0.28
● Estimated glomerular filtration rate,
ml/min/1.73 m2
85 ± 20
● Fasting glucose, mg/dl 105 ± 43
Table 1 Clinical characteristics of the HyperGEN study
sample (Continued)
● Total serum cholesterol, mg/dl 197 ± 39
● High density lipoprotein, mg/dl 51 ± 15
● Low density lipoprotein, mg/dl 119 ± 34
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global longitudinal strain, and e’ velocity (Model 2).
After additional adjustment for e’ velocity (Model 3) and
E/e’ ratio (Model 4), DWS was still associated global
longitudinal and circumferential strains.
Utility of DWS for the prediction of abnormal cardiac
mechanics: validation study
To determine the clinical utility of DWS as a predictor
of abnormal myocardial strain, we conducted a prospect-
ive validation study using digital speckle-tracking echo-
cardiography at high frame rates of 50–70 fps.Table 2 Echocardiographic characteristics the HyperGEN
study sample
Parameter All patients (N = 1907)
2D/Doppler echocardiographic parameter
LV end-systolic volume, ml* 48 ± 15
LV end-diastolic volume, ml* 127 ± 27
LV ejection fraction, %* 63 ± 6
LV midwall shortening, %* 17.9 ± 1.8
Mitral valve deceleration time, ms 204 ± 58
E/A ratio†, ‡ 1.59 ± 0.46
Isovolumic relaxation time, ms 80 ± 18
Left atrial diameter, cm 3.4 ± 0.5
Interventricular septal wall thickness, cm 1.3 ± 0.1
LV mass index, g/m2 * 84 ± 19
LV hypertrophy, n (%)* 317 (17)
Posterior wall thickness at end-systole, cm 1.37 ± 0.14
Posterior wall thickness at end-diastole, cm 0.85 ± 0.12
Diastolic wall strain, % 0.38 ± 0.05
Speckle-tracking echocardiographic parameter
Global radial strain, % 27.0 ± 11.7
Global circumferential strain, % 21.0 ± 5.1
Global longitudinal strain, % 14.8 ± 3.5
Septal e’ velocity, cm/s 7.1 ± 1.8
Lateral e’ velocity, cm/s 10.5 ± 2.1
Average e’ velocity, cm/s 8.8 ± 1.8
Septal E/e’ ratio† 10.6 ± 3.4
Lateral E/e’ ratio† 7.0 ± 1.9
Average E/e’ ratio† 8.7 ± 2.5
*LV = Left ventricular; †E = Early mitral inflow velocity; ‡A = Late (atrial) mitral
inflow velocity.
Figure 2 Left ventricular diastolic indices versus quintiles of
diastolic wall stiffness in HyperGEN. Bar graphs depict the
relationship between diastolic wall strain and left ventricular e’
velocity and E/e’ ratio.
Figure 1 Left ventricular systolic strain versus quintiles of
diastolic wall strain in HyperGEN. Bar graphs depict the relationship
between diastolic wall strain and left ventricular global longitudinal
strain, global circumferential strain, and global radial strain.
Selvaraj et al. Cardiovascular Ultrasound 2014, 12:40 Page 6 of 10
http://www.cardiovascularultrasound.com/content/12/1/40Scatterplots depicting the relationship between DWS and
peak systolic strains in this study are shown in Figure 3.
We found that DWS (mean ± SD = 0.38 ± 0.04) correlated
well with global longitudinal, circumferential, and radial
strains, and was most highly correlated with global radial
strain (Table 5). On ROC analysis, DWS demonstrated
good discriminative ability (i.e., area under the ROC curve)
for the detection of abnormal strain values (Table 5).
Discussion
In one of the largest speckle-tracking studies to date,
using echocardiograms from 1907 HyperGEN participants,
we found that DWS correlated with both systolic and
diastolic indices of LV performance and was independ-
ently associated with several indices of abnormal cardiac
mechanics. These findings were significant after control-
ling for EF, LV mass index, and even diastolic indices of
impaired relation (tissue e’ velocity) and filling pressures
(E/e’ ratio). Our study is the first to comprehensively
Table 3 Correlation of diastolic wall strain with systolic





Global radial strain, % 0.07 0.002
Global circumferential strain, % 0.07 0.004
Global longitudinal strain, % 0.15 <0.001
Ejection fraction, % 0.03 0.19
Midwall shortening, % 0.56 <0.001
Diastolic indices
e’ velocity, cm/s 0.23 <0.001
E/e’ ratio† −0.07 0.03
Isovolumic relaxation time, ms −0.19 <0.001
E/A ratio†, ‡ 0.16 0.001
Early mitral inflow deceleration time, ms −0.05 0.07
EDV20, mL* −0.001 0.97
*EDV20= left ventricular (LV) end-diastolic volume at an idealized LV end-diastolic
pressure of 20 mmHg; †E = Early mitral inflow velocity; ‡A = Late (atrial) mitral
inflow velocity.
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stolic echocardiographic parameters as well as the first
to show the association of DWS with indices of systolic
and diastolic cardiac mechanics. DWS, we conclude, is
an overall marker of cardiac performance, including
systolic and diastolic mechanics, but it is not a marker
of LV diastolic chamber stiffness.
Few studies have examined the correlation of DWS with
echocardiographic indices. The correlation between DWS
and tissue e’ velocity has been confirmed [3]. Previous
studies have disagreed on the correlation between DWS
and E/e’ ratio [3,4]. In our large study, however, we
failed to find a correlation with E/e’. We also found no
correlation between DWS and EDV20 or mitral inflow
deceleration time, both established non-invasive markers
of LV stiffness. We do, however, provide here the first evi-
dence of significant correlations and associations betweenTable 4 Association of cardiac mechanics with diastolic wall s
Dependent
variable





GRS,% 0.02 (−0.08, 0.12) 0.71 0.12 (0.003, 0.24)
GCS,% 0.13 (−0.03, 0.06) 0.58 0.05 (0.003, 0.10)
GLS,% 0.10 (0.07, 0.12) <0.001 0.07 (0.04, 0.10)
e’ velocity, cm/s 0.08 (0.07, 0.11) <0.001 0.03 (0.01, 0.05)
E/e’ ratio −0.03 (−0.06, 0.01) 0.15 0.02 (−0.03, 0.06)
*Adjusted for speckle-tracking analyst, image quality, field center, and family related
†Adjusted for all covariates in Model 1 plus age, sex, left ventricular mass-index, wa
‡Includes all covariates from Model 2 with additional adjustment for average tissue
§Includes all covariates from Model 2 with additional adjustment for average E/e’ ra
GRS = Global radial strain; GCS = Global circumferential strain; GLS = Global longitudiDWS and systolic echocardiographic indices (i.e., systolic
strains) in humans. Interestingly, significant correlations
between DWS and systolic parameters were not observed
in an animal study, but this study consisted of only 25 rats
and may have been underpowered [4].
Notably, Takeda et al., who first established the use of
DWS to evaluate LV stiffness, did not find a correlation
with tissue Doppler derived strain [4]. This may reflect
the greater challenges of measuring strain with tissue
Doppler technology versus speckle-tracking echocardi-
ography, which is a direct marker of Lagrangian strain,
less angle dependent, and more reproducible [5]. The
association found in our study was indeed expected
based on the mathematical formulations of both DWS
and strain. However, in HyperGEN, DWS surprisingly
did not have the strongest association with global radial
strain, which is somewhat akin to DWS mathematically.
However, it should be noted that DWS is measured from
the posterior wall in the parasternal long axis and thus
measures transverse strain, which differs from radial
strain. In addition, the modest association between DWS
and radial strain in HyperGEN likely reflects the greater
difficulty in measuring global radial strain using speckle-
tracking software. The radial motion of speckles acquired
in the parasternal short axis view may fall out of line with
the direction of the ultrasound beam, which causes poorer
resolution of this motion and worse software tracking
ability [20]. Based on our prospective digital speckle-
tracking analysis of 35 patients, in which we found that
DWS correlated best with radial strain, it is likely that
technical issues are the primary reason for the only modest
association between DWS and radial strain in HyperGEN.
Our study provides some insight into why DWS inde-
pendently predicts adverse outcomes in patients with
heart failure and preserved ejection fraction (HFpEF)
[3]. Decreased DWS in HFpEF may be associated with
poor outcomes through its association with abnormal
systolic cardiac mechanics in addition to its association
with abnormal diastolic cardiac mechanics. Other studiestrain in HyperGEN






0.049 0.12 (−0.01, 0.25) 0.06 0.16 (0.00, 0.32) 0.046
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Figure 3 Scatterplots demonstrating the correlation between
diastolic wall strain and peak systolic strains measured
prospectively on digital speckle-tracking analysis. On
prospective speckle-tracking analysis, DWS was most closely
associated with global radial strain.




Global longitudinal strain < 12.5% 0
Global circumferential strain < 15% 0
Global radial strain < 35% 0
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in HFpEF [21,22], including reduced longitudinal, circum-
ferential, and radial strain [23,24]. Though not specifically
studied in HFpEF patients, abnormalities in strain inde-
pendently predict mortality [25], which raises the possibility
that DWS predicts mortality in HFpEF perhaps as a marker
of abnormal cardiac mechanics.
We therefore caution the clinical use of DWS as a pure
marker of LV diastolic stiffness, since DWS is independ-
ently associated with abnormal systolic cardiac mechanics
and correlates with both systolic and diastolic echocar-
diographic indices. The failure to DWS to correlate
with other non-invasive measurements of LV stiffness is
particularly remarkable. Why Takeda et al. were able to
find a correlation between DWS and myocardial stiffness,
while the present study did not, may be multifactorial.
First, DWS is an abbreviated term from the original
equation that sought to quantify LV stiffness, the epicar-
dial motion index [(DWS)/(epicardial movement during
diastole)] [4]. Though the epicardial motion index is a
more exact marker of LV diastolic stiffness, this formula
requires direct measurement of epicardial movement,
which is difficult to achieve with 2D echocardiography.
The epicardial motion index may better reflect LV
diastolic stiffness compared to DWS, but its difficult
implementation in routine clinical practice would reduce
its clinical utility. Second, despite a predominantly hyper-
tensive population, only 17% had echocardiographic
evidence of LV hypertrophy, thereby reducing our ability to
find a correlation between DWS and LV diastolic stiffness.
Finally, the difference in findings may relate to technique of
measurement of LV stiffness (invasive, catheter-based tech-
nique versus an non-invasive echocardiographic technique).
Further research should be performed to determine more
precisely the clinical utility of DWS.
Our results should be interpreted in the context of a
few limitations. First, DWS is measured in the parasternal
long axis view, whereas cardiac mechanics were measured
in our study in the parasternal short axis and apical
four chamber views. Thus, we did not assess myocardial
mechanics precisely at the posterior wall in the parasternal
long axis view where DWS is derived. Second, because
HyperGEN echocardiographic data were collected at a
time prior to tissue Doppler imaging, tissue velocities
were recorded here using speckle-tracking analysis.
However, we demonstrated that correlation between thelic wall strain as a marker of abnormal cardiac mechanics
Correlation with DWS ROC analysis
R P-value C-statistic (95% CI)
.61 0.0001 0.78 (0.61-0.95)
.57 0.0003 0.79 (0.61-0.97)
.73 <0.0001 0.84 (0.71-0.97)
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http://www.cardiovascularultrasound.com/content/12/1/40two approaches is high and were able to convert our
measurements into tissue Doppler values. Third, speckle-
tracking was performed retrospectively on echocardiograms
that were acquired without specific attention to optimizing
endocardial border definition, a necessity for speckle-
tracking software [5]. This may have accounted for the
modest correlation coefficients for the relationship
between DWS and systolic and diastolic parameters.
However, the majority of images acquired were of at
least adequate quality. In addition, image quality was
entered into all regression analyses, and we purposely
performed a prospective validation study to verify our
findings in HyperGEN, and these data show that DWS
is indeed clinically useful as an estimator of abnormal
cardiac mechanics. Fourth, we are unable to calculate
the myocardial performance index due to missing relevant
data in the dataset, which should theoretically correlate
with DWS if it is indeed an overall marker of myocardial
function. Finally, our validation study was too small to
reliably calculate clinically valid sensitivities and specific-
ities (and optimal cut-off values) for DWS as a diagnostic
test for abnormal systolic strain values. Further study will
be necessary to determine whether DWS can be applied
clinically.
Conclusion
DWS correlates with both systolic and diastolic echocar-
diographic parameters. In addition, DWS is independently
associated with multiple measures of systolic cardiac
mechanics. DWS appears to reflect overall myocardial
performance, and caution should be exercised clinically
implementing this index to assess LV diastolic stiffness.
Nevertheless, given its ease of use and widespread applic-
ability, calculation of DWS could be a powerful new tech-
nique for the detection of subclinical cardiac disease.
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